LUMIscience
The computed 12-month bankruptcy probability of LUMIscience is 1.2% (low). The 2024 annual accounts show equity of €11k and a net result of €-9k. Its solvency ranks better than 64% of 52 sector peers (fiscal year 2024). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €11k |
| Net result | €-9k |
| Staff (FTE) | 1 |
| Better than sector | 64% |
Fragile profile, watch profitability in particular.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 23.0% | 3.8% | |
| Net result | €-9k | €-6k | |
| Equity | €11k | €2k | |
| Gross operating margin | €-6k | €-2k | |
| Total assets | €48k | €87k |
| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €-7k |
| Net profit | €-9k |
| Cash flow | €-7k |
| Staff costs | €566 |
| Income taxes | - |
| Dividends | - |
| Total assets | €48k |
| Equity | €11k |
| Debt | €37k |
| of which ≤ 1y | €37k |
| of which > 1y | - |
| Working capital | €-4k |
| Employees (FTE) | 1.0 |
| 2024 | |
|---|---|
| Current ratio | 0.90 |
| Quick ratio | 0.90 |
| Working capital ratio | -7.7% |
| Solvency | 23.0% |
| Debt / equity | 3.35 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -18.9% |
| ROE | -82.1% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €48k |
| Fixed assets | 21/28 | €15k |
| Intangible fixed assets | 21 | €15k |
| Current assets | 29/58 | €33k |
| Amounts receivable within one year | 40/41 | €15k |
| Cash & bank | 54/58 | €18k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €48k |
| Equity | 10/15 | €11k |
| Contributions / capital | 10/11 | €20k |
| Accumulated profits (losses) | 14 | €-9k |
| Amounts payable | 17/49 | €37k |
| Amounts payable within one year | 42/48 | €37k |
| Trade debts payable within one year | 44 | €2k |
| Income statement | ||
| Gross operating margin | 9900 | €-6k |
| Operating result | 9901 | €-9k |
| Result before taxes | 9903 | €-9k |
| Net result for the period | 9904 | €-9k |
| Result to be appropriated | 9905 | €-9k |
| NACE primary | 20420 |
| Legal form | Private limited company(610) |
| Incorporation | 29-01-2024 |
| Status | Active |
| Postal code | 8670 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 38502G0190/00A000 | Flanders | 2,785 m² | 1 · 204 m² | 9.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | LUMIscience |